It was not until the application of immunohistochemistry and the capability to grow cultures of Reed-Sternberg cells from classic Hodgkin lymphoma (CHL) by Volker Diehl, Harald Stein, and colleagues in Germany that the discovery of the CD30 antigen was possible in 1982 [5]. Here, TNFRSF8 is linked to classic Hodgkin lymphoma.